Keywords
body mass index
Lequesne index
Western Ontario & McMaster Universities Osteoarthritis index
How to Cite
Abstract
In press
Background. The aging of the population, the prevalence of gonarthrosis, and the the epidemic of overweight highlight the relevance of the study.
Aim. To determine the effectiveness of the treatment algorithm for persons of older age groups with gonarthrosis of the II–III degree and functional insufficiency of the I–II degree, excessive body weight in the conditions of martial law by means of statistical processing of the obtained results.
Materials and Methods. The study continued during 2022–2025 in the polyclinic of the Municipal Non-Profit Enterprise of the Kharkiv Regional Council "Regional Clinical Hospital". 100 older patients with gonarthrosis of II–III degree and functional insufficiency of I–II degree, and overweight, who were divided into three groups according to treatment tactics, were examined. Group I and Group II patients received oral chondroprotectors and used articulated orthoses. After 3 months, patients of Group I were injected with hyaluronic acid intra-articularly during a follow-up examination. Patients in all groups received topical and oral non-steroidal anti-inflammatory drugs. All patients signed a consent to participate in the study. Statistical processing of the Lequesne index and Western Ontario & McMaster Universities Osteoarthritis index was carried out using SPSS 27 (IBM, USA).
Results and Conclusions. According to the Kolmogorov-Smirnov criterion, the normal distribution of the studied indicators was confirmed. Combined treatment of patients of Group I (orthoses, chondroprotectors and hyaluronic acid) proved to be statistically and clinically effective in older patients with gonarthrosis of II–III degree and functional insufficiency of I–II degree against the background of overweight. Group II patients needed further optimization of treatment, and Group III – active intervention. The results obtained were similar to some foreign and domestic studies.
Keywords: degenerative-dystrophic diseases, body mass index, Lequen index, Western Ontario & McMaster Universities Osteoarthritis index.
References
Osteoarthritis. World Health Organization, 14 Jul 2023 [Internet]. Available at: https://www.who.int/news-room/fact-sheets/detail/osteoarthritis [accessed 21 Mar 2025].
Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30(2):160-7. DOI: 10.1097/BOR.0000000000000479. PMID: 29227353.
Long H, Liu Q, Yin H, Diao N, Zhang Y, Lin J, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: Findings from the global burden of disease study 2019. Arthritis Rheumatol. 2022;74(7):1172-83. DOI: 10.1002/art.42089. PMID: 35233975.
Lementowski PW, Zelicof SB. Obesity and osteoarthritis. Am J Orthop (Belle Mead NJ). 2008;37(3):148-51. PMID: 18438470.
Geng R, Li J, Yu C, Zhang C, Chen F, Chen J, et al. Knee osteoarthritis: Current status and research progress in treatment (Review). Exp Ther Med. 2023;26(4):481. DOI: 10.3892/etm.2023.12180. PMID: 37745043.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. DOI: 10.1016/S0140-6736(20)30925-9. Erratum in: Lancet. 2020;396(10262):1562. DOI: 10.1016/S0140-6736(20)32226-1. PMID: 33069326.
Osadchuk TI, Kalashnikov AV, Khyts OV. Gonarthrosis: prevalence and differential approach to endoprosthesis. Ukrainian Medical Journal. 2023;6(146):80-4. DOI: 10.32471/umj.1680-3051.146.222998. [In Ukrainian].
Albassam M, Aslam M. Testing Internal Quality Control of Clinical Laboratory Data Using Paired t-Test under Uncertainty. Biomed Res Int. 2021;2021:5527845. DOI: 10.1155/2021/5527845. PMID: 34527738.
Zhou Y, Zhu Y, Wong WK. Statistical tests for homogeneity of variance for clinical trials and recommendations. Contemp Clin Trials Commun. 2023;33:101119. DOI: 10.1016/j.conctc.2023.101119. PMID: 37143826.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.